Therapeutic Apheresis Therapies
Our Therapeutic Apheresis Program provides high quality patient care, while substantially reducing the cost of these services to the hospital.
We Provide:
- Plasmapheresis
- Leukocytapheresis
- Thrombocytapheresis
- Erythrocytapheresis
- LDL Apheresis
- Photopheresis
- Cell Therapy Services
- Medical consultation related to any aspect of therapeutic apheresis
Diseases Commonly Treated with Therapeutic Apheresis:
- Thrombotic Thrombocytopenic Purpura (TTP)
- Guillain-Barre Syndrome (GBS)
- Myasthenia Gravis
- Autoimmune Polyneuropathies
- Waldenstrom’s Macroglobulinemia
- Goodpasture’s Syndrome
- Rapidly Progressive Glomerulonephritis
- Cryoglobulinemia
- Sickle Cell Disease
- Systemic Lupus Erythematosus
- Pulmonary Renal Syndrome
Benefits to the Hospital:
- Commitment of providing high quality of care demonstrated by our national Quality Assessment and Improvement (QAI) Program tailored to the apheresis setting
- National policies and procedures, staff credentialing, internal audits, on-site experts during regulatory review
- Exceptional patient care by experienced certified medical staff
- Eliminates the hospital’s need for expensive medical equipment and the overhead of running a specialized department
- Reduces patient ICU hospital days
- Experienced local Medical Directors providing oversight
- National medical oversight of general program by specialized team
- Continuing education and ongoing competency assessments
Contact Information:
Telephone: 877-369-0547
Email: InpatientServices@fmc-na.com